Olgotrelvir as a Single-Agent Treatment of Nonhospitalized Patients with Covid-19.

已完结 10 由 CELINE 发布于 2024/5/29 9:10:42

DOI:10.1056/EVIDoa2400026
作者：Rongmeng Jiang, Bing Han, Wanhong Xu, Xiaoying Zhang, Chunxian Peng, Qiang Dang, Wei Sun, Ling Lin, Yuanlong Lin, Lingyan Fan, Dongqing Lv, Lei Shao, Ying Chen, Yunqing Qiu, Limei Han, Weixiang Kong, Guangming Li, Kai Wang, Jie Peng, Bingliang Lin, Zhaowei Tong, Xiaobo Lu, Lifeng Wang, Feng Gao, Jiemei Feng, Yongxia Li, Xiaojun Ma, Jinxiang Wang, Shanbo Wang, Wei Shen, Chao Wang, Kuan Yan, Zhenhao Lin, Can Jin, Long Mao, Jia Liu, Yulia Kushnareva, Olivia Kotoi, Zhenghong Zhu, Mike Royal, Mark Brunswick, Henry Ji, Xiao Xu, Hongzhou Lu
文献类型：期刊论文
补充材料：只需要正文

其它数据库

Abstract：Background: Olgotrelvir is an oral antiviral with dual mechanisms of action targeting severe acute respiratory syndrome coronavirus 2 main protease (i.e., Mpro) and human cathepsin L. It has

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Association for the Advancement of Science (AAAS)Terminal C(sp3)–H borylation through intermolecular radical sampling